2022 ASM / R-0112
Diagnostic Accuracy and Complications in Percutaneous Transthoracic Computer Tomography-Guided Lung Biopsies: A Retrospective Clinical Audit
Keywords:
Interventional non-vascular, Respiratory system, CT, Biopsy, Cancer, Outcomes
Authors:
J. Lim, L. K. Ng
DOI:
10.26044/ranzcr2022/R-0112
Methods and materials
- Lung cancer is the most prevalent cause of cancer-related mortality in New Zealand [1].
- Computed tomography (CT) guided lung biopsies are a powerful diagnostic tool in the assessment of lung lesions, particularly where flexible bronchoscopy cannot be used to obtain samples – for instance, in peripherally located lesions [2, 3].
- This analysis includes CT-guided lung biopsies undertaken by an interventional radiologist between July 2016 and October 2021, at Waitematā DHB.
- Imaging, histology and follow up results were retrieved from the health information system Clinical Portal.
- A total of 51 lung biopsy patients were included in this audit.
- 17 (33.3%) patients had fine needle aspirations (FNA) only and the remaining 34 (66.7%) patients had both FNA and core needle biopsy.
- None of the patients had a core needle biopsy only.